The trading of substandard pharmaceutical raw material seems to be proliferating in the Baddi-Barotiwala-Nalagarh (BBN) industrial area with several cases of spurious drugs coming to the fore since September last year.
In this fictional case, the CEO of a global pharmaceutical company based in Belgium with operations in Moscow is contemplating what to do in the wake of Russia’s invasion of Ukraine in February 2022. The company is experiencing pressure from shareholders, Ukrainian and Belgium government officials, and the public to follow in the footsteps of many multinational corporations and cease operations in Russia. However, since the firm provides medically necessary products, the decision isn’t straightforward. How can the CEO navigate the complicated political waters of this decision and make the most humanitarian decision? Should the company exit Russia completely, or should it continue to operate but on a smaller scale? Expert commentators respond.
A large cache of spurious drugs was recovered by the Drug Control Administration (DCA) from the premises of Arya Pharma at Dharampur village in Baddi last evening. The firm was manufacturing allopathic drugs illegally despite having a licence for nutraceuticals. Nutraceutical is a combination of nut